Patrì A, Fabbrocini G. Possible role of neuropilins in dermatological manifestations of SARS-CoV-2 infection. Int J Dermatol.
2021;60(7):e265....
Asghar F, Shamim N, Farooque U, et al. Telogen Effluvium: a
review of the literature. Cureus. 2020;12(5):e8320. https://doi.
org/10.7759/cureus.8320.
Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9
(9):1–3. https://doi.org/10.7860/JCDR/2015/15219.6492.
Rebora A. Telogen effluvium: a comprehensive review. Clin
Cosmet Investig Dermatol. 2019;12:583–590. https://doi.org/10.
2147/CCID.S200471.
Headington JT. Telogen effluvium. New concepts and review.
Arch Dermatol. 1993;129(3):356–363. https://doi.org/10.1001/
archderm.129.3.356.
Tosi A, Misciali C, Piraccini BM, et al. Drug-induced hair loss
and hair growth. Incidence, management and avoidance. Drug
Saf. 1994;10(4):310–317....
Kligman AM. The human hair cycle. J Invest Dermatol. 1959;33:
307–316. https://doi.org/10.1038/jid.1959.156.
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More
than 50 long-term effects of COVID-19: a systematic review
and meta-analysis. Sci...
Czech T, Sugihara S, Nishimura Y. Characteristics of hair loss
after COVID-19: a systematic scoping review. J Cosmet
Dermatol. 2022;21(9):3655–3662....
Ohyama M, Matsudo K, Fujita T. Management of hair loss after
severe acute respiratory syndrome coronavirus 2 infection:
insight into the pathophysiology...
Domínguez-Santás M, Haya-Martínez L, Fernández-Nieto D,
et al. Acute telogen effluvium associated with SARS-CoV-2
infection. Aust J Gen Pract....
Kutlu Ö, Metin A. Relative changes in the pattern of diseases
presenting in dermatology outpatient clinic in the era of the
COVID-19 pandemic....
Hussain N, Agarwala P, Iqbal K, et al. A systematic review of
acute telogen effluvium, a harrowing post-COVID-19 manifestation. J Med Virol....
Moreno-Arrones OM, Lobato-cerezo A, Gomez-Zubiaur A, et al.
SARS-CoV-2-induced telogen effluvium: a multicentric study.
J Eur Acad Dermatol...
Grover C, Khurana A. Telogen effluvium. Indian J Dermatol
Venereol Leprol. 2013;79(5):591–603. https://doi.org/10.4103/
0378-6323.116731.
Gentile P. Hair loss and telogen effluvium related to COVID-19:
the potential implication of adipose-derived mesenchymal
stem cells and platelet-rich...
Inamadar AC. Covid induced telogen effluvium (CITE): an
insight. Indian Dermatol Online J. 2022;13(4):445–448. https://doi.
org/10.4103/idoj.idoj_139_22.
Arenas R. La piel. Arenas. Dermatología: Atlas, diagnóstico y
tratamiento. Ciudad de México: Mc Graw Hill; 2019. p. 1–25.
Khezri MR, Ghasemnejad-Berenji M. The probable mechanism
of hair loss in patients with COVID-19. Am J Dermatopathol.
2022;44(7):539–541. https://doi.org/10.1097/DAD.
0000000000002145.
Ye Q, Wang B, Mao J. The pathogenesis and treatment of the
‘Cytokine Storm’ in COVID-19. J Inf Secur. 2020;80(6):607–613.
https://doi.org/10.1016/j.jinf.2020.03.037.
Ito T, Ito N, Saathoff M, et al. Interferon-gamma is a potent
inducer of catagen-like changes in cultured human anagen
hair follicles. Br...
Kwack MH, Ahn JS, Kim MK, et al. Dihydrotestosteroneinducible IL-6 inhibits elongation of human hair shafts by
suppressing matrix cell proliferation...
Rumaisyah A, Natalisa D, Putri GK, et al. Acute telogen
effluvium related to COVID-19 infection: a review. J Pak Assoc
Dermatol. 2022;32(3):598–604.
Salamanna F, Maglio M, Landini MP, et al. Body localization of
ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med.
2020;7:e594495....
Mazeto IFS, Brommonschenkel CC, Miola AC, et al.
Ultrastructural evidence for anagen hair follicle infection with
SARS-CoV-2 in early-onset...
Wang YY, Po HL. Enoxaparin-induced alopecia in patients
with cerebral venous thrombosis. J Clin Pharm Ther. 2006;31(5):
513–517. https://doi.org/10.1111/j.1365-2710.2006.00769.x.
Aksoy H, Yıldırım UM, Ergen P, et al. COVID-19 induced telogen
effluvium Dermatol Ther. 2021;34(6):e15175. https://doi.org/10.
1111/dth.15175.
Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19
syndrome. Nat Med. 2021;27:601–615. https://doi.org/10.1038/
s41591-021-01283-z.
Müller-Ramos P, Ianhez M, Silva de Castro CC, et al. PostCOVID-19 hair loss: prevalence and associated factors among
5,891 patients. Int J...
Abrantes TF, Artounian KA, Falsey R, et al. Time of onset and
duration of post-COVID19 Acute telogen effluvium. J Am Acad
Dermatol. 2021;85(4):975–976....
Starace M, Iorizzo M, Sechi A, et al. Trichodynia and telogen
effluvium in COVID-19 patients: results of an international
expert opinion survey...
Chien Yin GO, Siong-See JL, Wang ECE. Telogen Effluvium - a
review of the science and current obstacles. J Dermatol Sci.
2021;101(3):156–163....
Aguilar S, Agüero-Zaputovich MF. Efluvio telógeno: revisión de
la literatura. Gaceta Dermatológica (Asunción). 2022;16(1):80–89.
Rossi A, Magri F, Sernicola A, et al. Telogen effluvium after
SARS-CoV-2 infection: a series of cases and possible pathogenetic mechanisms....
Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol.
2002;27(5):389–395. https://doi.org/10.1046/j.1365-2230.2002.
01080.x.
Ocampo-Garza SS, Vastarella M, Nappa P, et al. Telogen
effluvium in the new SARS-CoV-2 era. Int J Dermatol. 2021;60
(7):e265–e266. https://doi.org/10.1111/ijd.15482.
Rebora A. Trichodynia: a review of the literature. Int J Dermatol.
2016;55:382–384. https://doi.org/10.1111/ijd.13204.
Nguyen B, Tosti A. Alopecia in patients with COVID-19:
A systematic review and meta-analysis. JAAD Int. 2022;7:
67–77. https://doi.org/10.1016/j.jdin.2022.02.006.